Clinical Trials
Gene Therapy Trials – A Word of Advice From FDA Officials
Representatives from the US FDA Center for Biologics Evaluation and Research Office of Tissues and Advanced Therapies have said that the gene therapy clinical...
Drug Research
Cancer Vaccine Redesign – A Transformation In The Making
Researchers at Northwestern University's International Institute for Nanotechnology (IIN) have devised a novel method for dramatically increasing the potency of practically any vaccine. The...
Drug Research
RMAT Status Given To Cardiac Gene Therapy – A First From FDA
The Regenerative Medicine Advanced Therapies designation of RP-A501, which happens to be an adeno-associated virus-based gene therapy when it comes to the treatment of...
News
4 Factors That Pharma Supply Chains Need To Address Swiftly
The post-pandemic future of healthcare has compelled one to re-evaluate the supply chain from end-to-end.
Be it new technologies, shortened clinical trials, next-gen medical innovations,...
IT & Data Management
3 Life Sciences Innovation Factors To Watch Out For In 2023
In 2023, there are going to be numerous factors that will influence the life science sector, in turn forcing leaders to re-evaluate existing practises...
Packaging & Labelling
Gerresheimer and Corning announce joint venture to meet growing demand for Velocity Vials, accelerating the delivery of lifesaving treatments
Gerresheimer AG, the leading global provider of healthcare, beauty, and drug delivery systems for pharma, biotech, and cosmetics, today announced a joint venture with...
Clinical Trials
Genenta expands pact with AGC Biologics to make cell therapy products for trials
Genenta Science, a clinical-stage biotechnology company, has entered into a development and manufacturing service agreement (MSA) with AGC Biologics S.p.A. to manufacture cell therapy...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read